Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine the safety and efficacy of Imiquimod, a Toll-like
receptor 7 agonist in breast cancer (for chestwall recurrences or metastases to the skin).
Phase:
Phase 2
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health